Akademisyen
AYKUT TURHAN
DOKTOR ÖĞRETİM ÜYESİ
ATATÜRK ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Tıbbi Onkoloji (İç Hastalıkları)
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 41
- Proje 0
- Kitap 0
- Bildiri 10
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
2
Q2
8
Q3
4
Q4
6
WoS (JCR)
Q1
4
Q2
6
Q3
3
Q4
6
TR Index
16
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
0
Üst %10 makale
1
Ort. yüzdelik
33.0%
Üst %1 payı
0.0%
Üst %10 payı
2.6%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2026 Distinguishing adrenal metastases from benign lesions in NSCLC: the value of clinical and radiological parameters YÖKSİS SJR Q2 JCR Q2 OpenAlex 24.3%
- 2026 Prognostic Value of the Objective Prognostic Score and Palliative Prognostic Index for Short-Term Mortality in Terminal Cancer Patients Receiving Best Supportive Care: A Prospective Observational Single-Center Study YÖKSİS SJR Q2 JCR Q1 OpenAlex 60.5%
- 2026 Clinicopathological Predictors of Pathologic Complete Response in Triple-Negative Breast Cancer: Impact of Platinum-Based Neoadjuvant Chemotherapy YÖKSİS TR Index OpenAlex 24.7%
- 2026 The impact of digital health technology use on oncology-specific clinical guideline adherence among medical oncologists in Turkiye YÖKSİS TR Index OpenAlex 71.5%
- 2026 Real-world outcomes of regorafenib in metastatic colorectal cancer: a single-center retrospective study YÖKSİS TR Index OpenAlex 15.8%
- 2025 Magnesium Depletion Score as a Prognostic Indicator in Endometrial Cancer: A Retrospective Cohort Study YÖKSİS JCR Q2 OpenAlex 34.6%
- 2025 Prognostic Value of the PILE Score in Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy YÖKSİS SJR Q2 JCR Q1 OpenAlex 82.0%
- 2025 New Parameters That May Predict Tumor Regression and Survival in Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer YÖKSİS TR Index SJR Q4 JCR Q3 OpenAlex 27.1%
- 2025 Survival Comparison and Clinical Characteristics of Sunitinib and Pazopanib in the Treatment of Metastatic Renal Cell Cancer, Single Center Real-Life Data YÖKSİS OpenAlex 33.4%
- 2025 Molecular subtypes and clinicopathological characteristics of breast cancer across age groups: a retrospective analysis YÖKSİS TR Index OpenAlex 14.4%
- 2025 Cancer Data, Case Increase Rates and Future Prospects in the Northeastern Anatolia Region of Türkiye, a Special Region for Gastric and Esophageal Cancers in 2018-2023 YÖKSİS TR Index OpenAlex 1.1%
- 2024 The Effect of C-Reactive Protein/Lymphocyte Ratio (CLR) on PFS in Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors: A Novel Biomarker YÖKSİS SJR Q2 JCR Q2 OpenAlex 81.7%
- 2024 Inflammatory parameters in NSCLC with driver mutation YÖKSİS SJR Q3 JCR Q4 OpenAlex 48.1%
- 2024 Tumor Lysis Syndrome Due to Pembrolizumab Use in Metastatic Nasopharyngeal Carcinoma YÖKSİS TR Index OpenAlex 10.4%
- 2024 The importance of adropin and hypoxia inducible factor-1 alpha in gastric cancer YÖKSİS OpenAlex 7.5%
- 2023 The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancer YÖKSİS SJR Q1 JCR Q2 OpenAlex 86.7%
- 2022 A Rare Synchronous Tumor Association in a Geriatric Patient: Lung Adenocarcinoma and Colon Carcinoma YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 1.4%
- 2022 Lipegfilgrastim may cause hyperleukocytosis YÖKSİS SJR Q3 JCR Q4 OpenAlex 38.7%
- 2022 A Rare Synchronous Tumor Association in a Geriatric Patient: Lung Adenocarcinoma and Colon Carcinoma YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 1.4%
- 2022 Evaluation of eating disorders, kinesiophobia and dysfunctional attitudes in patients with type 2 diabetes mellitus YÖKSİS SJR Q4 OpenAlex 50.7%